stone disease

Difficult stones present treatment, training challenges
Difficult stones present treatment, training challengesIn this interview, Dr. Wong describes difficult stones, discusses the skills and training required to treat them, and outlines the role of different treatment modalities.
Do you think shock wave lithotripsy should be retired?Despite ureteroscopy's high success results, there is still a role for shock wave lithotripsy in treating stones, urologists say.
What drives unplanned returns post-URS lithotripsy?The authors sought to identify factors associated with 30-day emergency department visits and readmission following URSLL.
Non-adherence to stone meds raises hospitalization riskWhen it comes to urinary stone disease, it appears that prescribers know what they’re doing. According to a study presented at the World Congress of Endourology and SWL in London, non-adherence to kidney stone medications led to a significant increase in adverse health outcomes.
Single-use ureteroscope yields high-quality imagesFindings from preclinical studies evaluating the performance of an investigational single-use digital flexible ureteroscope (Lithovue, Boston Scientific) support it as a viable alternative to current non-disposable flexible digital and fiberoptic ureteroscopes, said Brian H. Eisner, MD, at the World Congress of Endourology and SWL in London.
Breaking new ground (and kidney stones) with ultrasoundNovel ultrasound-based techniques for propelling and breaking kidney stones could soon join ESWL and URS in the urologist’s treatment armamentarium. In this interview, Michael Bailey, PhD, discusses how these technologies work, what they’re capable of, and where they are in development.
Pre-op antibiotics sufficient to prevent UTI during stone TxBrian Howard Eisner, MD, examined antibiotic use in ureteroscopy and PCNL in two studies presented at the AUA annual meeting in New Orleans. He discusses the studies’ findings with Urology Times.
Does stone-related atherosclerosis start in childhood?Researchers compared artery thickness in children with and without kidney stones.
New Products: FDA approves oral agent for HSDD, app helps men with erectile dysfunction and moreIn this round-up of new urology products and services, learn about the FDA approving an oral agent for HSDD, an app that helps men with erectile dysfunction, and more.
Alpha-blocker may have benefit in larger stonesWhile there is no benefit from using tamsulosin (Flomax) versus placebo for the treatment of small ureteral stones, there is a potential upside of increased passage from using the drug to treat 5- to 10-mm stones, according to a study from Australia published online in the Annals of Emergency Medicine (July 13, 2015).